Non-Small Cell Lung Cancer: ASCO Tumor Boards

Product ID : NSCLTB17
Price: $15.00
You will receive a link to your product from customerservice@asco.org within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend

Purchase

Description

This is a case-based activity that includes discussion of a 75-year-old male former smoker who initially presented with right shoulder, back and chest pain, and headaches.

 

At the end of this course, users should be able to:

  • Evaluate the role of pembrolizumab, either alone or in combination in 1st line patients with advanced NSCLC
  • Analyze the patterns of failure and survival of postoperative brain radiation for resected dominant brain metastasis
  • Apply criteria for use of hippocampal sparing in whole brain radiation
  • Describe the potential impact of hippocampal avoidance during  whole brain radiation and the importance of supporting ongoing clinical trials

 

IMPORTANT NOTE: This course expires on November 15, 2020. Participants must complete all necessary course components by this date.

 

Purchase the 2017 ASCO Tumor Boards Bundle to access to all 2017 ASCO Tumor Boards for added savings. Purchased separately, these items would be $180 altogether. When bundled, you save $55.